iANTHUS CAPITAL HOLDINGS (ITHUF) Shares Outstanding (Weighted Average) (2020 - 2026)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Shares Outstanding (Weighted Average) came in at $7.0 billion in Q1 2026, up 3.38% year-on-year from $6.7 billion in Q1 2025, and up 3.92% quarter-over-quarter from $6.7 billion in Q4 2025.

iANTHUS CAPITAL HOLDINGS (ITHUF) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $7.0 billion for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $7.0 billion, up 3.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 billion (up 3.38% YoY), and the FY2025 annual result was $6.7 billion, up 2.49% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $7.0 billion for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $6.7 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $7.0 billion in Q1 2026 to a low of $3.4 million in Q4 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $6.5 billion (2024), against an average of $4.6 billion.
  • Across the five-year window, Shares Outstanding (Weighted Average) surged 2524759.88% in 2022 and plunged 98.88% in 2023, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Shares Outstanding (Weighted Average) stood at $3.4 million in 2022, then surged by 190834.72% to $6.4 billion in 2023, then grew by 1.59% to $6.5 billion in 2024, then advanced by 2.49% to $6.7 billion in 2025, then climbed by 3.92% to $7.0 billion in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $7.0 billion (Q1 2026), $6.7 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn 6.96 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.96 Bn
Dec 31, 2025 6.70 Bn
Sep 30, 2025 6.70 Bn
Jun 30, 2025 6.75 Bn
Mar 31, 2025 6.74 Bn
Dec 31, 2024 6.54 Bn
Sep 30, 2024 6.54 Bn
Jun 30, 2024 6.54 Bn
Mar 31, 2024 6.57 Bn
Dec 31, 2023 6.44 Bn
Sep 30, 2023 6.43 Bn
Jun 30, 2023 6.41 Mn
Mar 31, 2023 6.42 Mn
Dec 31, 2022 3.37 Mn
Jun 30, 2022 572.11 Mn
Mar 31, 2022 171.72 Mn
Dec 31, 2021 171,718.00
Sep 30, 2021 171,718.00
Jun 30, 2021 22,659.00
Mar 31, 2021 171.72 Mn